-pro-
capromab pendetide
capromab
abituzumab
alfuzosin
-col-
prostein
tenatumomab
conatumumab
figitumumab
tigatuzumab
inotuzumab
adecatumumab
acrixolimab
naptumomab estafenatox
duligotuzumab
-got-
nofetumomab
drozitumab
avelumab
patritumab
sipuleucel-T
panitumumab
prostate-specific antigen
oleclumab
PSA blood test
onartuzumab
lintuzumab
nacolomab tafenatox
matuzumab
dacetuzumab
lexatumumab
oncopeptide
cixutumumab
mapatumumab
ramucirumab
dulanermin
pamrevlumab
prostatic adenocarcinoma
samalizumab
inotuzumab ozogamicin
dalotuzumab
etaracizumab
ertumaxomab
prostate cancer
apolizumab
catumaxomab
-tum-
-mar-
sibrotuzumab
altumomab
labetuzumab
onapristone
immunocytokine
lucatumumab
bunazosin
cabazitaxel
satumomab
antiprostate
teprotumumab
p53
malignin
probasin
tamsulosin
cemiplimab
folliculin
arcitumomab
immunokinase
pemtumomab
silodosin
cantuzumab
votumumab
detumomab
pritumumab
durvalumab
carlumab
malignoma
blinatumomab
minretumomab
apalutamide
volociximab
flutamide
ensituximab
taplitumomab
darolutamide
bavituximab
naxitamab
nilutamide
prostasphere
relatlimab
prostate specific antigen
besilesomab
milatuzumab
plasmacytoma
edrecolomab
prostatosphere
monospecific
-les-
PSA